Organogenesis Holdings (NASDAQ: ORGO) , a regenerative health products specialist, shot skyward Thursday thanks to its inclusion on a key stock market index.
On Wednesday, after market close, S&P Dow Jones Indices -- operator of the famous S&P family of indexes -- announced a pair of changes to two of those indexes. Organogenesis healthcare sector peer Cantel Medical is being removed from the S&P MidCap 400 index, as it's being acquired by Steris .
Image source: Getty Images.
For further details see:
Why Organogenesis Holdings Blasted 7.7% Higher Today